For example, the oxazepin-4-one A (Figure 1) is a strong inhibitor of angiotensin-converting enzyme (ACE) [1] and found to play a prominent role in the current approaches to hypertension and diabetic nephropathy therapy, end-organ protection and heart failure treatment [6]. This evidence concerns the gene ACE and diabetic kidney disease.